Home / PLEC Knockout Cell Lines

PLEC Knockout Cell Lines

Gene: PLEC

Official Full Name: plectinprovided by HGNC

Gene Summary: Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO07294 PLEC Knockout cell line (HeLa) Human PLEC 1:3~1:6 Negative Online Inquiry
KO07295 PLEC Knockout cell line (HCT 116) Human PLEC 1:2~1:4 Negative Online Inquiry
KO07296 PLEC Knockout cell line (HEK293) Human PLEC 1:3~1:6 Negative Online Inquiry
KO07297 PLEC Knockout cell line (A549) Human PLEC 1:3~1:4 Negative Online Inquiry

Background

PLEC Gene Knockout Cell Lines are genetically modified cellular models designed specifically to study the functionality and role of the PLEC gene in various biological processes. Through the utilization of precise gene-editing technologies such as CRISPR/Cas9, these cell lines have been engineered to lack functional PLEC gene expression. This allows researchers to investigate the downstream effects of its knockout on cellular behavior, signaling pathways, and potential disease mechanisms, particularly in connective tissue disorders and cancer.

The primary mechanism of action for these cell lines involves the disruption of normal PLEC gene function, which encodes for the protein plectin—a critical cytoskeletal linker involved in maintaining cell integrity and adhesion. By negating its expression, researchers can discern the contributions of plectin to cellular architecture and stability as well as its interactions with other cellular components, fostering a deeper understanding of disease states associated with its dysregulation.

The scientific importance of PLEC Gene Knockout Cell Lines extends to their application in both research and clinical settings. These cell lines serve as invaluable tools for elucidating cellular mechanisms underlying diseases and testing potential therapeutic agents targeting plectin-associated pathways. Their relevance is particularly noteworthy in fields such as regenerative medicine, oncology, and biotechnology, where understanding cell behavior and growth can lead to novel treatment strategies and improved patient outcomes.

Compared to traditional methods of studying gene function, such as knockdown approaches or overexpression models, PLEC Gene Knockout Cell Lines offer distinct advantages. They provide a complete absence of the target gene product, allowing for unequivocal analysis of gene function without the confounding effects of residual activity. Additionally, these cell lines can be used for high-throughput screening, facilitating accelerated research efforts.

For researchers, clinicians, and other stakeholders in the scientific community, PLEC Gene Knockout Cell Lines represent a significant advancement in gene function studies, allowing for precision and clarity in experimental design. By harnessing the latest advancements in gene-editing technology, these cell lines stand as a testament to our commitment to empowering research and discovery.

Our company specializes in the provision of high-quality biological materials designed to advance scientific investigation and enable breakthroughs in understanding complex biological questions. We stand by our expertise in generating reliable, innovative research tools tailored to meet the dynamic needs of today's research landscape.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.